Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SNSSD

Sunesis Pharmaceuticals, Inc. (MM) (SNSSD)

Sunesis Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSSD
DateTimeSourceHeadlineSymbolCompany
03/10/20117:30AMGlobeNewswire Inc.Sunesis Issued Important European Patent Covering Vosaroxin Clinical FormulationNASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
03/09/20117:29AMGlobeNewswire Inc.Sunesis to Present at ROTH 23rd Annual OC Growth Stock ConferenceNASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
03/03/20117:30AMGlobeNewswire Inc.Sunesis Pharmaceuticals Regains NASDAQ ComplianceNASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
03/02/20118:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
03/02/20118:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
03/02/20118:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
03/01/20117:30AMGlobeNewswire Inc.Sunesis to Present at Cowen and Company 31st Annual Health Care ConferenceNASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
02/24/20118:46AMMarketwiredRegulatory Process an Ongoing Challenge for Speculative Biotech FirmsNASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
02/24/20117:30AMGlobeNewswire Inc.Sunesis to Join Panel Discussion at the RBC Capital Markets' Healthcare ConferenceNASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
02/23/20117:30AMGlobeNewswire Inc.Sunesis Receives FDA Fast Track Designation for Vosaroxin in AMLNASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
02/18/20114:17PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSDSunesis Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:SNSSD